Fexuprazan (Fexuclue)
Erosive Esophagitis (GERD)
FiledUnder Review in Japan
Key Facts
Indication
Erosive Esophagitis (GERD)
Phase
Filed
Status
Under Review in Japan
Company
About KYORIN Pharmaceutical
KYORIN Pharmaceutical is a mid-sized, revenue-generating Japanese pharmaceutical company with a diversified portfolio spanning prescription drugs, over-the-counter (OTC) products, and veterinary medicines. The company leverages its expertise in respiratory and urological diseases to maintain a stable revenue base from commercial products while investing in R&D for future growth. Its strategic focus includes lifecycle management of key brands and advancing its pipeline through internal research and selective partnerships.
View full company profileTherapeutic Areas
Other Erosive Esophagitis (GERD) Drugs
| Drug | Company | Phase |
|---|---|---|
| Fexuprazan | Nxera Pharma | Phase 3 |